The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target

• Benjamin D. Ferguson,

  Affiliations Pritzker School of Medicine, University of Chicago, Chicago, Illinois, United States of America, Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Ren Liu,

  Affiliation Department of Medicine, Division of Medical Oncology, University of Southern California, Los Angeles, California, United States of America

  ⨯
• Cleo E. Rolle,

  Affiliation Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Yi-Hung Carol Tan,

  Affiliation Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Valery Krasnoperov,

  Affiliation Vasgene Therapeutics, Inc., Los Angeles, California, United States of America

  ⨯
• Rajani Kanteti,

  Affiliation Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Maria S. Tretiakova,

  Affiliation Department of Pathology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Gustavo M. Cervantes,

  Affiliation Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Rifat Hasina,

  Affiliation Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Robyn D. Hseu,

  Affiliation Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• A. John Iafrate,

  Affiliation Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• Theodore Karrison,

  Affiliation Department of Health Studies, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Mark K. Ferguson,

  Affiliations Department of Surgery, University of Chicago, Chicago, Illinois, United States of America, Comprehensive Cancer Center, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Aliya N. Husain,

  Affiliation Department of Pathology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Leonardo Faoro,

  Affiliation Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Everett E. Vokes,

  Affiliation Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Parkash S. Gill,

  Affiliations Department of Medicine, Division of Medical Oncology, University of Southern California, Los Angeles, California, United States of America, Vasgene Therapeutics, Inc., Los Angeles, California, United States of America

  ⨯
•  [ ... ],
• Ravi Salgia

  * E-mail: rsalgia@medicine.bsd.uchicago.edu

  Affiliations Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America, Comprehensive Cancer Center, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• [ view all ]
• [ view less ]